Heat therapy vs surgery for overactive parathyroid glands
Part of Hormones & metabolism clinical trials.
This trial compares two treatments for secondary hyperparathyroidism: thermal ablation (using heat to destroy overactive parathyroid tissue) and parathyroidectomy (surgical removal). It may help patients whose parathyroid hormone levels stay very high despite medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your intact parathyroid hormone (iPTH) level must be above 800 pg/mL
- You have not responded well to medications like calcimimetics or vitamin D
- You have symptoms like severe bone pain, muscle pain, or calcium deposits in soft tissues
- An imaging test (ultrasound or similar) shows at least one enlarged parathyroid gland
- You do not have serious bleeding problems, severe heart or lung issues, or unstable vital signs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two treatments for primary hyperparathyroidism: a minimally invasive heat procedure (thermal ablation) versus traditional surgery (parathyroidectomy). It aims to find which option works better for controlling symptoms and calcium levels.
This trial tests combining heat treatment of the thyroid gland with antithyroid medications to treat primary hyperthyroidism (an overactive thyroid). It may help patients who haven't responded well to standard drugs, had side effects, or want faster symptom relief.
This trial compares two surgical approaches for severe secondary hyperparathyroidism caused by kidney disease: removing all parathyroid tissue alone versus removing it and moving some tissue back into the body. The study aims to see which approach works better and is safer for controlling the hormone problem.
This trial tests a new sensor tool that helps surgeons check if a parathyroid gland is healthy during surgery for primary hyperparathyroidism. It may help doctors decide whether to remove or save the gland, improving outcomes.
This trial looks at whether removing overactive parathyroid glands (parathyroidectomy) can help people who still have high calcium or low phosphate levels more than 6 months after a kidney transplant. If you have stable kidney function and meet certain blood test results, you may be able to join.
This study wants to see if measuring parathyroid hormone (PTH) levels during surgery helps guide how much parathyroid tissue to remove. It is for people who need surgery for hyperparathyroidism caused by kidney disease.
Hear when a new Efficacy and Safety trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.